Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2008-05-02
2010-12-14
Huynh, Phuong (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S172100, C424S178100, C435S007100, C435S007240, C210S323100, C604S006030
Reexamination Certificate
active
07850969
ABSTRACT:
The present invention provides a module for reducing the activity of leukocytes which comprises a carrier and a ligand that is linked to the carrier and is suitable for interacting with a leukocyte receptor. Furthermore, the present invention provides a process for reducing the activity of leukocytes using said module. The advantage of the present invention is that after binding the activated leukocytes in the leukocyte inactivation module (LIM), the damaging effect of the cells is inhibited within minutes.
REFERENCES:
patent: 5639376 (1997-06-01), Lee et al.
patent: 5840083 (1998-11-01), Braach-Maksvytis
patent: 6204055 (2001-03-01), Dean et al.
patent: 6797514 (2004-09-01), Berenson et al.
patent: 691 19 683 (1990-07-01), None
patent: 10147638 (2003-04-01), None
patent: 1 010 428 (2000-06-01), None
patent: 9518665 (1995-07-01), None
patent: 9712632 (1997-04-01), None
patent: 9738707 (1997-10-01), None
patent: 9846242 (1998-10-01), None
Watson R. W. G. et al., “Regulation of Fas antibody induced neutrophil apoptosis is both caspase and mitochondrial dependent” FEBS Letters, Elsevier Science Publishers, Amsterdam, NL, vol. 453, No. 1-2, Jun. 18, 1999, pp. 67-71.
Cinatl J Jr et al., “Decreased neutrophil adhesion to human cytomegalovirus-infected retinal pigment epithelial cells is mediated by virus-induced up-regulation of Fas ligand independent of neutrophil apoptosis.” Journal of Immunology (Baltimore, MD.: 1950) United States Oct. 15, 2000, vol. 165, No. 8, pp. 4405-4413.
R. William G. Watson, et al., “Regulation of Fas antibody induced neutrophil apoptosis is both caspase and mitochondrial dependent” FEBS Letters, vol. 453, No. 1-2, pp. 67-71, Jun. 18, 1999.
Francois et al, Biomaterials 17:667-678, 1996.
Jindrich Cinatl. Jr., et al., “Decreased neutrophil adhesion to human cytomegalovirus-infected retinal pigment epithelial cells is mediated by virus-induced up-regulation of Fas ligand independent of neutrophil apoptosis” Journal of Immunology, vol. 165, No. 8, pp. 4405-4413, Oct. 15, 2000.
Desbarats et al, Proc natl. Acad Sci USA 93:11014-11018, Oct. 1996.
Garrone et al, J Exp Med 182: 1265-1273, 1995.
Hata et al, Leukemia & Lymphoma 24(1-2): 35-42, Dec. 1996.
Stryer et al, in Biochemistry, Third edition, W H Freeman Company, New York, pp. 31-33, 1998.
Yoshida-Kato et al, Biosci Biotechnol. Biochem 64(9): 1903-1908, 2000.
Rudikoff et al, Proc Natl Acad Sci USA 1982 vol. 79, p. 1979.
Kobrin et al, J. Immunology 146:2017-2020, 1991.
Barrios et al, J. Molecular Recognition 17: 332-338, 2004.
Huynh Phuong
Leukocare GmbH
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
LandOfFree
Leukocyte inactivation module does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Leukocyte inactivation module, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Leukocyte inactivation module will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4195270